Feasibility of using real world evidence to inform decisions on conducting a cost effectiveness analysis- an example of stroke risk reduction therapies in atrial fibrillation

Authors:

Saunders O, Akehurst R, Zhong Y, Amorosi S, Gavaghan M, Hemstock M, Wong T and Panikker S.

Publication type:

Conference Proceedings – Poster

Publication Name:

ISPOR Europe 2019

Citation:

Saunders O, Akehurst R, Zhong Y, Amorosi S, Gavaghan M, Hemstock M, Wong T and Panikker S. Feasibility of using real world evidence to inform decisions on conducting a cost effectiveness analysis- an example of stroke risk reduction therapies in atrial fibrillation. 19th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Copenhagen, Denmark. 2-6 November 2019. PCV114.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies